Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets
暂无分享,去创建一个
Xiaoqiang Qiu | X. Qiu | Dongping Huang | Qian Chen | Xiaoyun Zeng | Dongping Huang | Xiaoyun Zeng | Qian Chen
[1] Peng Wang,et al. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG. , 2017, Biochemical and biophysical research communications.
[2] Liang Zhou,et al. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. , 2012, Biochemical and biophysical research communications.
[3] Yong-Jian Xu,et al. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer , 2014, Oncotarget.
[4] Suning Ding,et al. Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion , 2012, Journal of Cancer Research and Clinical Oncology.
[5] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[6] H. Dweep,et al. miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.
[7] B. Sherman,et al. A novel microRNA, hsa-miR-6852 differentially regulated by Interleukin-27 induces necrosis in cervical cancer cells by downregulating the FoxM1 expression , 2018, Scientific Reports.
[8] Xiaokun Li,et al. MicroRNA-509-5p functions as an anti-oncogene in breast cancer via targeting SOD2. , 2017, European Review for Medical and Pharmacological Sciences.
[9] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[10] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[11] J. Hanprasertpong,et al. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer , 2018, Oncology Research and Treatment.
[12] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.
[13] V. Kim,et al. Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.
[14] M. von Knebel Doeberitz,et al. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. , 2009, The Lancet. Oncology.
[15] Trevor J Pugh,et al. Landscape of genomic alterations in cervical carcinomas , 2013, Nature.
[16] Guang-cai Li,et al. MicroRNA‐374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM‐2 , 2018, Journal of cellular physiology.
[17] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[18] A. Izzotti,et al. Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators. , 2017, American journal of cancer research.
[19] F. Buonaguro,et al. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review. , 2013, Gynecologic oncology.
[20] Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research , 2018, Scientific Reports.
[21] D. Weisenberger,et al. Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma , 2018, Hepatology.
[22] Fangyu Shi,et al. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis. , 2017, Oncology letters.
[23] Lin-Ping Kang,et al. MicroRNA‐92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer , 2018, Cancer medicine.
[24] Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery , 2014, Journal of Hematology & Oncology.
[25] Y. Hu,et al. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma. , 2016, Cancer letters.
[26] Jun Yu,et al. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis , 2016, Molecular Cancer.
[27] Y. Mo,et al. miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF α , 2014, Oncogene.
[28] N. Kawada,et al. Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer. , 2013, Oncology reports.
[29] M. Raffeld,et al. Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases , 2012, Clinical Cancer Research.
[30] S. Mortimer,et al. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients , 2017, Clinical Cancer Research.
[31] H. Nagawa,et al. Loss of Smad4 protein expression and 18qLOH as molecular markers indicating lymph node metastasis in colorectal cancer—a study matched for tumor depth and pathology , 2008, Journal of surgical oncology.
[32] H.-R. Shi,et al. MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway. , 2017, European review for medical and pharmacological sciences.
[33] Mei-qi Zhang,et al. microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma , 2017, Oncotarget.
[34] Xiangguo Duan,et al. MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase‑associated protein 2. , 2017, Molecular medicine reports.
[35] Jian Zhao,et al. miR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1α. , 2016, American journal of translational research.
[36] I. Christensen,et al. Risk of recurrence, prognosis, and follow‐up for Danish women with cervical cancer in 2005‐2013: A national cohort study , 2018, Cancer.
[37] D. Schadendorf,et al. Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma , 2018, Clinical Cancer Research.
[38] T. Maehara,et al. Significance of lymphatic invasion and cancer invasion‐related proteins on lymph node metastasis in gastric cancer , 2009, Journal of gastroenterology and hepatology.
[39] N. Hadi,et al. Notch1 ligand signaling pathway activated in cervical cancer: poor prognosis with high-level JAG1/Notch1 , 2015, Archives of Gynecology and Obstetrics.
[40] Xiaohong Wang,et al. Overexpression of miR-509 Increases Apoptosis and Inhibits Invasion via Suppression of Tumor Necrosis Factor-α in Triple-Negative Breast Cancer Hs578T Cells , 2016, Oncology research.
[41] San-Gang Wu,et al. The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix , 2017, Cancer management and research.
[42] Damian Szklarczyk,et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..
[43] W. -. Zhang,et al. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma , 2013, Irish Journal of Medical Science.
[44] Shu-Chun Lin,et al. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. , 2006, Cancer letters.
[45] T. R. Lee,et al. miR-526b targets 3′ UTR of MMP1 mRNA , 2015, Experimental & Molecular Medicine.
[46] Martin Kuiper,et al. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..
[47] Huayao Li,et al. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers , 2018, Journal of cellular biochemistry.
[48] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[49] W. Guo,et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. , 2004, Carcinogenesis.
[50] Yan Yang,et al. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer , 2013, Journal of Experimental & Clinical Cancer Research.
[51] Jing Dong,et al. Upregulation of Long Non-Coding RNA Small Nucleolar RNA Host Gene 12 Contributes to Cell Growth and Invasion in Cervical Cancer by Acting as a Sponge for MiR-424-5p , 2018, Cellular Physiology and Biochemistry.
[52] D. Landsittel,et al. Correlation of Protease-Activated Receptor-1 With Differentiation Markers in Squamous Cell Carcinoma of the Head and Neck and Its Implication in Lymph Node Metastasis , 2004, Clinical Cancer Research.
[53] Qi Zhou,et al. MicroRNA‐497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF‐1 , 2018, Journal of cellular physiology.
[54] Gary D. Bader,et al. An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.
[55] Fan-guo Meng,et al. MiR-508-5p is a prognostic marker and inhibits cell proliferation and migration in glioma. , 2017, European review for medical and pharmacological sciences.
[56] H. Park,et al. Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer , 2012, Cancer science.
[57] Xiaoying Shen,et al. RhoT1 and Smad4 Are Correlated with Lymph Node Metastasis and Overall Survival in Pancreatic Cancer , 2012, PloS one.
[58] F. Wang,et al. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer. , 2018, The international journal of biochemistry & cell biology.
[59] M. Munsell,et al. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. , 2015, Gynecologic oncology.
[60] miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer , 2017, Scientific Reports.
[61] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..